Dibenedetto SP - Search Results

1

Detection of minimal residual disease: methods and relationship to outcome in T-lineage acute lymphoblastic leukemia.

Dibenedetto SP, Lo Nigro L, Di Cataldo A, Schilirò G. Dibenedetto SP, et al. Leuk Lymphoma. 1998 Dec;32(1-2):65-75. doi: 10.3109/10428199809059247. Leuk Lymphoma. 1998. PMID: 10037002 Review.

2

Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.

Dibenedetto SP, Lo Nigro L, Mayer SP, Rovera G, Schilirò G. Dibenedetto SP, et al. Blood. 1997 Aug 1;90(3):1226-32. Blood. 1997. PMID: 9242556 Free article.

3

Diabetes insipidus 9 years after cessation of therapy for acute lymphoblastic leukemia.

Dibenedetto SP, Mancuso GR, Samperi P, Di Cataldo A, Ragusa R, Caruso-Nicoletti M. Dibenedetto SP, et al. Pediatr Hematol Oncol. 1991 Jul-Sep;8(3):231-3. doi: 10.3109/08880019109033456. Pediatr Hematol Oncol. 1991. PMID: 1742181

4

Assessment of the value of treatment with granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a randomized clinical trial.

Dibenedetto SP, Ragusa R, Ippolito AM, Lo Nigro L, Di Cataldo A, D'Amico S, Miraglia V. Dibenedetto SP, et al. Eur J Haematol. 1995 Aug;55(2):93-6. doi: 10.1111/j.1600-0609.1995.tb01816.x. Eur J Haematol. 1995. PMID: 7543060 Clinical Trial.

5

Levels of L-asparagine in CSF after intramuscular administration of asparaginase from Erwinia in children with acute lymphoblastic leukemia.

Dibenedetto SP, Di Cataldo A, Ragusa R, Meli C, Lo Nigro L. Dibenedetto SP, et al. J Clin Oncol. 1995 Feb;13(2):339-44. doi: 10.1200/JCO.1995.13.2.339. J Clin Oncol. 1995. PMID: 7844595 Clinical Trial.

6

[Acute lymphoblastic leukemia in children. Results of treatment in Sicily 1987-1992].

Di Cataldo A, Dibenedetto SP, Ragusa R, Miraglia V, D'Amico S, Lo Nigro L, Schilirò G. Di Cataldo A, et al. Among authors: dibenedetto sp. Presse Med. 1994 Sep 24;23(28):1293-8. Presse Med. 1994. PMID: 7984526 French.

7

6-Mercaptopurine cumulative dose: a critical factor of maintenance therapy in average risk childhood acute lymphoblastic leukemia.

Dibenedetto SP, Guardabasso V, Ragusa R, Di Cataldo A, Miraglia V, D'Amico S, Ippolito AM. Dibenedetto SP, et al. Pediatr Hematol Oncol. 1994 May-Jun;11(3):251-8. doi: 10.3109/08880019409141668. Pediatr Hematol Oncol. 1994. PMID: 8060809

8

Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia.

Dibenedetto SP, Ragusa R, Sciacca A, Di Cataldo A, Miraglia V, D'Amico S, Lo Nigro L, Ippolito AM. Dibenedetto SP, et al. Eur J Pediatr. 1994 Apr;153(4):271-5. doi: 10.1007/BF01954518. Eur J Pediatr. 1994. PMID: 8194562

9

Growth and growth hormone in children during and after therapy for acute lymphoblastic leukaemia.

Caruso-Nicoletti M, Mancuso M, Spadaro G, Dibenedetto SP, DiCataldo A, Schiliró G. Caruso-Nicoletti M, et al. Among authors: dibenedetto sp. Eur J Pediatr. 1993 Sep;152(9):730-3. doi: 10.1007/BF01953986. Eur J Pediatr. 1993. PMID: 8223802

10

Reduction in the incidence of infection by hepatitis C virus in children with acute lymphoblastic leukemia after suspension of sampling from the finger.

Dibenedetto SP, Miraglia V, Ippolito AM, D'Amico S, Lo Nigro L, Ragusa R, Schilirò G. Dibenedetto SP, et al. Pediatr Infect Dis J. 1996 Mar;15(3):265-6. doi: 10.1097/00006454-199603000-00018. Pediatr Infect Dis J. 1996. PMID: 8852917 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters